BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35659199)

  • 1. Yin Yang 1-induced activation of LINC01133 facilitates the progression of pancreatic cancer by sponging miR-199b-5p to upregulate myelin regulatory factor expression.
    Yang X; Wang L; Zhou F; Ye S; Sun Q
    Bioengineered; 2022 May; 13(5):13352-13365. PubMed ID: 35659199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of LINC01133 in Osteogenic Differentiation of Dental Pulp Stem Cells by Targeting miR-199b-5p.
    Shi Q; Zheng M
    Oral Health Prev Dent; 2022 Apr; 20(1):173-184. PubMed ID: 35481341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long Non-Coding RNA Differentiation Antagonizing Nonprotein Coding RNA (DANCR) Promotes Proliferation and Invasion of Pancreatic Cancer by Sponging miR-214-5p to Regulate E2F2 Expression.
    Yao Z; Chen Q; Ni Z; Zhou L; Wang Y; Yang Y; Huang H
    Med Sci Monit; 2019 Jun; 25():4544-4552. PubMed ID: 31213582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA BANCR Promotes Pancreatic Cancer Tumorigenesis via Modulating MiR-195-5p/Wnt/β-Catenin Signaling Pathway.
    Wu X; Xia T; Cao M; Zhang P; Shi G; Chen L; Zhang J; Yin J; Wu P; Cai B; Lu Z; Miao Y; Jiang K
    Technol Cancer Res Treat; 2019; 18():1533033819887962. PubMed ID: 31769353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linc01133 contributes to gastric cancer growth by enhancing YES1-dependent YAP1 nuclear translocation via sponging miR-145-5p.
    Sun Y; Tian Y; He J; Tian Y; Zhang G; Zhao R; Zhu WJ; Gao P
    Cell Death Dis; 2022 Jan; 13(1):51. PubMed ID: 35017464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-216a-5p inhibits tumorigenesis in Pancreatic Cancer by targeting TPT1/mTORC1 and is mediated by LINC01133.
    Zhang J; Gao S; Zhang Y; Yi H; Xu M; Xu J; Liu H; Ding Z; He H; Wang H; Hao Z; Sun L; Liu Y; Wei F
    Int J Biol Sci; 2020; 16(14):2612-2627. PubMed ID: 32792860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long Noncoding RNA LINC01133 Promotes the Malignant Behaviors of Renal Cell Carcinoma by Regulating the miR-30b-5p/Rab3D Axis.
    Zhai X; Wu Y; Wang Z; Zhao D; Li H; Chong T; Zhao J
    Cell Transplant; 2020; 29():963689720964413. PubMed ID: 33054325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LINC01133 as ceRNA inhibits gastric cancer progression by sponging miR-106a-3p to regulate APC expression and the Wnt/β-catenin pathway.
    Yang XZ; Cheng TT; He QJ; Lei ZY; Chi J; Tang Z; Liao QX; Zhang H; Zeng LS; Cui SZ
    Mol Cancer; 2018 Aug; 17(1):126. PubMed ID: 30134915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silencing long noncoding RNA LINC01133 suppresses pancreatic cancer through regulation of microRNA-1299-dependent IGF2BP3.
    Li S; Jiang F; Chen F; Deng Y; Huang H
    J Biochem Mol Toxicol; 2024 Jan; 38(1):e23534. PubMed ID: 37718503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA LINC00514 accelerates pancreatic cancer progression by acting as a ceRNA of miR-28-5p to upregulate Rap1b expression.
    Han Q; Li J; Xiong J; Song Z
    J Exp Clin Cancer Res; 2020 Aug; 39(1):151. PubMed ID: 32771045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silencing of long noncoding RNA LINC00958 prevents tumor initiation of pancreatic cancer by acting as a sponge of microRNA-330-5p to down-regulate PAX8.
    Chen S; Chen JZ; Zhang JQ; Chen HX; Qiu FN; Yan ML; Tian YF; Peng CH; Shen BY; Chen YL; Wang YD
    Cancer Lett; 2019 Apr; 446():49-61. PubMed ID: 30639194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA LINC00473 drives the progression of pancreatic cancer via upregulating programmed death-ligand 1 by sponging microRNA-195-5p.
    Zhou WY; Zhang MM; Liu C; Kang Y; Wang JO; Yang XH
    J Cell Physiol; 2019 Dec; 234(12):23176-23189. PubMed ID: 31206665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA HCP5 Regulates Pancreatic Cancer Progression by miR-140-5p/CDK8 Axis.
    Yuan B; Guan Q; Yan T; Zhang X; Xu W; Li J
    Cancer Biother Radiopharm; 2020 Nov; 35(9):711-719. PubMed ID: 32407143
    [No Abstract]   [Full Text] [Related]  

  • 14. LncRNA CYTOR promotes pancreatic cancer cell proliferation and migration by sponging miR-205-5p.
    Zhu H; Shan Y; Ge K; Lu J; Kong W; Jia C
    Pancreatology; 2020 Sep; 20(6):1139-1148. PubMed ID: 32732173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
    Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
    Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA small nucleolar RNA host gene 6 aggravates pancreatic cancer through upregulation of far upstream element binding protein 1 by sponging microRNA-26a-5p.
    Zhang XX; Chen H; Li HY; Chen R; He L; Yang JL; Xiao LL; Chen JL
    Chin Med J (Engl); 2020 May; 133(10):1211-1220. PubMed ID: 32433053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LINC01133 hampers the development of gastric cancer through increasing somatostatin via binding to microRNA-576-5p.
    Zhang L; Pan K; Zuo Z; Ye F; Cao D; Peng Y; Tang T; Li X; Zhou S; Duan L
    Epigenomics; 2021 Aug; 13(15):1205-1219. PubMed ID: 34318683
    [No Abstract]   [Full Text] [Related]  

  • 18. Long non-coding RNA LINC01207 silencing suppresses AGR2 expression to facilitate autophagy and apoptosis of pancreatic cancer cells by sponging miR-143-5p.
    Liu C; Wang JO; Zhou WY; Chang XY; Zhang MM; Zhang Y; Yang XH
    Mol Cell Endocrinol; 2019 Aug; 493():110424. PubMed ID: 30991076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel pyroptosis-associated lncRNA LINC01133 promotes pancreatic adenocarcinoma development via miR-30b-5p/SIRT1 axis.
    Li J; Lin J; Ji Y; Wang X; Fu D; Wang W; Shen B
    Cell Oncol (Dordr); 2023 Oct; 46(5):1381-1398. PubMed ID: 37138146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA PSMB8-AS1 contributes to pancreatic cancer progression via modulating miR-382-3p/STAT1/PD-L1 axis.
    Zhang H; Zhu C; He Z; Chen S; Li L; Sun C
    J Exp Clin Cancer Res; 2020 Sep; 39(1):179. PubMed ID: 32891166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.